Christopher S. Lathan

Also affiliated with Dana-Farber Cancer Institute

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Racial disparities in treatment delay among younger men with prostate cancer”.

Racial disparities in treatment delay among younger men with prostate cancer

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-021-00479-1

N/A

0DataRank · unranked

18 citations

Kosj Yamoah, Christopher S. Lathan, Vinayak Muralidhar, Brandon A. Mahal, Paul L. Nguyen +2 more

Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia

Haematologica(2023)10.3324/haematol.2023.283723

N/A

0DataRank · unranked

11 citations

Marlise R. Luskin, Irum Khan, Elizabeth Warner, Anand Patel, Thomas Walsh +4 more

Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia

Blood Cancer Journal(2023)10.1038/s41408-023-00964-x

N/A

0DataRank · unranked

2 citations

Colin Cernik, Hajime Uno, Thomas Walsh, Gregory S. Calip, Daniel J. DeAngelo +3 more

Are enrollment criteria for phase II and III clinical trials in acute myeloid leukemia arbitrarily restrictive?

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6525

N/A

0DataRank · unranked

0 citations

Thomas J. Walsh, Dillon Clancy, Marlise R. Luskin, Daniel J. DeAngelo, Christopher S. Lathan +2 more

Disparities in uptake of novel therapies for acute myeloid leukemia.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6540

N/A

0DataRank · unranked

0 citations

Colin Cernik, Hajime Uno, Thomas Walsh, Kasisomayajula Viswanath, Christopher S. Lathan +3 more

Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae067

N/A

0DataRank · unranked

12 citations

Andrew M. Brunner, Jesse J. Plascak, Hajime Uno, Juan C. Varela, Marlise R. Luskin +6 more

Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers

The Oncologist(2025)10.1093/oncolo/oyaf241

N/A

0DataRank · unranked

3 citations

Eric Blackstone, Anna Revette, Jane E. Roberts, Alice S. Mims, Daniel J. DeAngelo +3 more